Non-Small-Cell Lung Cancer in Elderly Patients: A Discussion of Treatment Options

被引：39

作者：

Gajra, Ajeet ^{[1
]}

Jatoi, Aminah ^{[2
]}

机构：

[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA

[2] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 24期

关键词：

PHASE-III TRIAL; VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; POOLED ANALYSIS; CHEST RADIOTHERAPY; OLDER PATIENTS; ONCOLOGY; CARBOPLATIN; PACLITAXEL;

D O I：

10.1200/JCO.2014.55.3099

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer is a disease of the elderly. In older patients, the management of a malignancy as complex and potentially as lethal as lung cancer is challenging. Despite the fact that a large proportion of patients with non-small-cell lung cancer are elderly, information remains scant on how best to treat these patients. The goal of this review is to discuss the published literature and to provide guidance on how to treat elderly patients within three broad stages: (1) metastatic cancer, (2) early-stage cancer after surgery, and (3) locally advanced inoperable cancer. Because decisions on how and when to prescribe systemic treatment can be particularly difficult, this review focuses heavily on chemotherapy-related treatment decisions with some discussion of emerging data on the use of the comprehensive geriatric assessment. (C) 2014 by American Society of Clinical Oncology

引用

页码：2562 / 2569

页数：8

共 63 条

[31] Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States [J].

Lang, Kathleen ;

Marciniak, Martin D. ;

Faries, Doug ;

Stokes, Michael ;

Buesching, Don ;

Earle, Craig ;

Treat, Joseph ;

Morissette, Nathalie ;

Thompson, David .

LUNG CANCER, 2009, 63 (02) :264-270

[32]

Langer CJ, 2002, JNCI-J NATL CANCER I, V94, P173

[33] Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer Safety of Avastin in Lung trial (MO19390) [J].

Laskin, Janessa ;

Crino, Lucio ;

Felip, Enriqueta ;

Franke, Fabio ;

Gorbunova, Vera ;

Groen, Harry ;

Jiang, Guo-liang ;

Reck, Martin ;

Schneider, Claus-Peter .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) :203-211

[34] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].

Le Chevalier, T ;

Arriagada, R ;

Le Péchoux, C ;

Grunenwald, D ;

Dunant, A ;

Pignon, JP ;

Tarayre, M ;

Abratt, R ;

Arriagada, R ;

Bergman, B ;

Gralla, R ;

Grunenwald, D ;

Le Chevalier, T ;

Orlowski, T ;

Papadakis, E ;

Pinel, MIS ;

Araujo, C ;

Della Torre, H ;

de Solchaga, MM ;

Abdi, E ;

Blum, R ;

Ball, D ;

Basser, R ;

De Boer, R ;

Bishop, J ;

Brigham, B ;

Davis, S ;

Fox, D ;

Richardson, G ;

Wyld, D ;

Pirker, R ;

Humblet, Y ;

Delaunois, L ;

Van Meerbeeck, JP ;

Germonpre, P ;

Vansteenkiste, J ;

Nackaerts, K ;

Pinel, MIS ;

Vauthier, G ;

Younes, RN ;

Arriagada, R ;

Baeza, R ;

Carvajal, P ;

Kleinman, S ;

Orlandi, L ;

Castro, C ;

Godoy, J ;

Kosatova, K ;

Gaafar, R ;

Azarian, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360

[35] Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL) [J].

Leighl, Natasha B. ;

Zatloukal, Petr ;

Mezger, Joerg ;

Ramlau, Rodryg ;

Moore, Nicola ;

Reck, Martin ;

Manegold, Christian .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) :1970-1976

[36] Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730) [J].

Lilenbaum, RC ;

Herndon, JE ;

List, MA ;

Desch, C ;

Watson, DM ;

Miller, AA ;

Graziano, SL ;

Perry, MC ;

Saville, W ;

Chahinian, P ;

Weeks, JC ;

Holland, JC ;

Green, MR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :190-196

[37] Therapy choices among older patients with lung carcinoma - An evaluation of two trials of the cancer and leukemia group B [J].

Lima, CMSR ;

Herndon, JE ;

Kosty, M ;

Clamon, G ;

Green, MR .

CANCER, 2002, 94 (01) :181-187

[38] Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy:: A prognostic analysis of the Multicenter Italian Lung Cancer in the Elderly Study [J].

Maione, P ;

Perrone, F ;

Gallo, C ;

Manzione, L ;

Piantedosi, FV ;

Barbera, S ;

Cigolari, S ;

Rosetti, F ;

Piazza, E ;

Robbiati, SF ;

Bertetto, O ;

Novello, S ;

Migliorino, MR ;

Favaretto, A ;

Spatafora, M ;

Ferraù, F ;

Frontini, L ;

Bearz, A ;

Repetto, L ;

Gridelli, C .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6865-6872

[39] Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study [J].

Morabito, Alessandro ;

Gebbia, Vittorio ;

Di Maio, Massimo ;

Cinieri, Saverio ;

Vigano, Maria Grazia ;

Bianco, Roberto ;

Barbera, Santi ;

Cavanna, Luigi ;

De Marinis, Filippo ;

Montesarchio, Vincenzo ;

Costanzo, Raffaele ;

Sandomenico, Claudia ;

Montanino, Agnese ;

Mancuso, Gianfranco ;

Russo, Paolo ;

Nacci, Angelo ;

Giordano, Pasqualina ;

Daniele, Gennaro ;

Piccirillo, Maria Carmela ;

Rocco, Gaetano ;

Gridelli, Cesare ;

Gallo, Ciro ;

Perrone, Francesco .

LUNG CANCER, 2013, 81 (01) :77-83

[40] The benefit of treatment intensification is age and histology-dependent in patients with locally advanced nonsmall cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies [J].

Movsas, B ;

Scott, C ;

Sause, W ;

Byhardt, R ;

Komaki, R ;

Cox, J ;

Johnson, D ;

Lawton, C ;

Dar, AR ;

Wasserman, T ;

Roach, M ;

Lee, JS ;

Andras, E .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05) :1143-1149

← 1 2 3 4 5 6 7 →